Dr. Hillary Blackburn

PHARMD, MBA

Testing Drug Quality & Safety with Valisure CEO, David Light

In this episode, we chat with David Light, Founder & CEO, of the pharmacy and analytical lab company about drug safety and quality. High-level overview of Valisure: — Valisure is the first ever pharmacy attached to a laboratory where every batch of medication is analyzed before being dispensed. — Valisure’s mission is to help ensure the safety, quality, and transparency in the medications it delivers to consumers. — All medications at Valisure come with a certificate of analysis, similar to nutritional information on food, and are sold at no additional cost. — Valisure currently rejects over 10% of the batches we analyze for problems related to dosage, dissolution (how a pill dissolves), and the presence of carcinogens. — Approximately 80% of medications in the U.S. are made from materials coming from India and China — The $2 trillion global pharma supply chain is incredibly complex and medications can touch 10-20 hands before reaching the consumer. Guest – David Light Founder & CEO, Valisure www.valisure.com Selected media highlights: New York Times: Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger Bloomberg News: Carcinogen Found by Pharmacy in Popular U.S. Diabetes Drug Washington Post Feature Story: A tiny pharmacy is identifying big problems with common drugs, including Zantac Bloomberg Businessweek 9/16/19 Cover Story: Carcinogens Have Infiltrated the Generic Drug Supply in the U.S. Reuters: Online pharmacy flags possible new impurity in blood pressure drug Valisure and Govzilla Drug Quality Scores Collaboration: Press Release (Jan 8, 2020) Rep. DeLauro Calls for Ranitidine Ban and Reintroduces Bill: Congressional Press Release (Valisure presented at joint press conference in US Capitol Building, Jan 10, 2020) Sen. Warren, Cotton, Kaine and Romney Letter on Drug Safety and Reliance on China: Congressional Press Release (Valisure data directly discussed and cited in letter, Dec 9, 2019) Covid-related: Reuters (3/19/20): Potential coronavirus treatment touted by Trump already in shortage, pharmacists say WSJ (2/28/20): FDA Cites Shortage of One Drug, Exposing Supply-Line Worry BioSpace (3/26/20): Some Drugs Being Rationed as Suppliers Continue to See Increased Orders The Hill (3/27/20): Trump must cut our dependence on Chinese drugs — whatever it takes Host – Hillary Blackburn, PharmD, MBA www.pharmacyadvisory.com https://www.linkedin.com/in/hillary-blackburn-67a92421/ @talktoyourpharmacist for Instagram and Facebook @HillBlackburn Twitter